Rob Berg

Rob Berg is a seasoned medical professional with extensive experience in oncology and drug development. Currently serving as Vice President of Medical Management at Syneos Health since October 2017, Rob leads a global team of 45 oncologists and hematologists, overseeing medical monitoring and clinical development strategies for biotech, pharmaceutical, and academic clients. Prior roles include Executive Medical Director at Oncology Drug Development in Practice, Senior Medical Director at INC Research, and Director roles at Merck and Organon, where responsibilities encompassed overseeing clinical development strategies, managing multicenter studies, and driving innovative drug discovery efforts. Rob holds a medical degree from Utrecht University and a PhD in skin cancer, complemented by specialized education in pharmaceutical medicine.